Jump to any asset 724 assets, updated daily
As of August 12, 2026, Morgan Stanley (MS) trades at $215.07. CleaRank Financial AI rates it Hold with a fair value of $200.00, 7.0% below the current price. Wall Street's consensus target is $215.07 across 25 analysts. RSI at 46 is in neutral territory, and the price is below its 50-day average of $216.24.

Morgan Stanley (MS)

Morgan Stanley NYSE

$215.07 -0.2600 (-0.12%)
At close: Aug 11, 4:00 PM EDT
AI Analyst Consensus
Hold
55 / 100

Morgan Stanley (MS) is currently trading at $215.07, a level that is above its 200-day and 20-day moving averages, indicating a generally positive long-term trend. However, the stock is currently trading below its 50-day SMA, suggesting some near-term weakness. The company operates within the Capital Markets industry, a segment of the broader Financial Services sector.

The most significant concern highlighted by the data is the substantial insider selling activity. Insiders have sold $98.7 million worth of stock against only $5.6 thousand in purchases, resulting in a heavy insider selling verdict. This net selling pressure, despite positive technicals like trading above the 200-day SMA, warrants caution. The strong revenue growth of 28% is a positive fundamental, but it is currently overshadowed by the insider sentiment and neutral technical momentum.

MS Price Analysis

Market Metrics

Open
$216.32
Day Range
$213.52 to $217.19
Prev Close
$215.33
Volume
2.38M
52-Week Range
$136.17 to $232.25
Market Cap
$338.09B

Peer Benchmarking

Valuation vs Sector (Financial Services)

Performance vs XLF

Sector Position Analysis
The stock's valuation metrics position it within the sector's competitive landscape, reflecting its market standing and growth trajectory relative to industry peers.

MS Analysis

Company's Health 4/5
AI Analyst Target +2.50% Upside
Target Price
$220.45
AI Technical Analysis Hold

Morgan Stanley's technicals present a mixed picture. The stock is trading above its 200-day SMA ($186.35) and its 20-day EMA ($214.88), suggesting underlying strength. However, it is currently positioned below its 50-day SMA ($216.24), indicating a potential short-term resistance level. The RSI at 45.61 falls within the neutral range, and the MACD at -0.17 suggests a lack of strong momentum in either direction.

The stochastic oscillator is at 70.61, nearing overbought territory, which could signal a potential pause or pullback. The CCI is slightly positive at 44.25. Overall, the technicals suggest a stock in consolidation, with key support at the 200-day SMA and resistance near the 50-day SMA. Traders should monitor the price action around these levels for directional cues.

ProTips
  • Monitor insider transaction patterns closely; a cessation of selling or initiation of buying could signal a shift in management sentiment.
  • Pay attention to the 50-day SMA ($216.24) as a key resistance level; a sustained break above this could indicate renewed bullish momentum.
  • Given the neutral RSI and MACD, consider strategies that are less sensitive to short-term price swings, or wait for clearer directional signals.
Key Catalysts
Bearish Heavy Insider Selling Pressure

Insiders have sold $98.7 million in stock versus only $5.6 thousand in purchases, indicating a strong heavy insider selling and potentially signaling management's lack of confidence in near-term stock appreciation.

Source: Insider Transactions
Bullish Strong Revenue Growth

Morgan Stanley reported a robust 28% revenue growth, significantly outperforming the sector average and indicating strong business expansion.

Source: Company Financials
Neutral Trading Above Key Moving Averages

The stock is currently trading above its 200-day ($186.35) and 20-day ($214.88) SMAs, suggesting underlying long-term strength despite recent consolidation.

Source: Technical Analysis
Neutral Neutral RSI Momentum

The Relative Strength Index (RSI) is at 45.61, falling within the neutral range and indicating a lack of strong buying or selling pressure in the immediate term.

Source: Technical Analysis
Market Outlook

The outlook for Morgan Stanley is cautiously neutral, balancing strong fundamental growth with significant insider selling. The stock's position above key long-term moving averages suggests resilience, but the current trading below the 50-day SMA and the heavy insider selling from insiders indicate potential for near-term choppiness or consolidation. A price target of $215.07, aligning with the current price and analyst median target, suggests limited immediate upside.

Upside potential could be unlocked if insider selling subsides and the stock breaks decisively above its 50-day SMA, potentially targeting higher resistance levels. Conversely, a breach of the 200-day SMA or continued heavy insider selling could signal a more significant downturn, especially if broader market sentiment shifts negatively for financial services firms.

Key Statistics

Market Cap 338.09B
P/E Ratio 17.36
EPS (TTM) 12.38
Dividend Yield 1.93%
52 Week High 232.25
52 Week Low 136.17

With a P/E ratio of 17.36 and EPS of $12.38, Morgan Stanley appears reasonably valued relative to its earnings, especially considering its strong revenue growth of 28%. The company's market capitalization stands at a substantial $338.09 billion. Compared to sector averages, its P/E is slightly above the average of 15.5, but its revenue growth significantly outpaces the sector's 8.0% average.

The dividend yield of approximately 1.93% offers a modest income stream. While the P/E ratio is not excessively high, the significant insider selling warrants a closer look at the underlying business drivers and future growth prospects. The company's financial health appears robust, but the current valuation needs to be weighed against the negative insider sentiment.

Earnings & Growth Analysis

Morgan Stanley's reported EPS of $12.38 suggests a profitable operation. While specific recent earnings performance details are not provided, the strong revenue growth of 28% indicates a positive top-line trajectory. Investors should monitor upcoming earnings reports for confirmation of sustained growth and profitability, especially in light of the current market conditions and insider selling activity.

Key Risks

The primary risk for Morgan Stanley is the significant insider selling, which signals a potential lack of confidence from management regarding near-term stock performance. Additionally, trading below the 50-day SMA suggests potential short-term headwinds and a risk of further price depreciation if key support levels are breached.

Technical Indicators i

RSI (14) 45.61
MACD -0.17
SMA 50 216.24
SMA 200 186.35
Technical Rating Bearish
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Neutral
Golden Cross in effect with the 50-day SMA ($216.24) above the 200-day SMA ($186.35), price is trading below the 50-day SMA.

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.72
Strong correlation
Nasdaq 100 (QQQ) +0.65
Moderate correlation
Bitcoin (BTC) +0.29
Weak correlation
Gold (XAU) +0.12
Weak correlation
Check Custom Correlation

MS Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Entry Strategies (click to switch)

CONSERVATIVE
$212.92
Slight discount to current
Wait for small dip
AGGRESSIVE
$215.07
At current price
Enter now if confident

Risk Management

STOP LOSS
$206.53
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (45.6) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$219.31
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$223.57
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$229.95
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
ℹ️ Disclaimer
This AI-generated trade plan for MS is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on August 12, 2026.

Compare Stocks

Compare stocks against top peers and benchmarks.

MS
215.07
-0.1207%
+ Compare

Risk & Volatility i

Risk Level Moderate
Daily Volatility
1.97%
30-day average
52-Week Range
$136.17 58% from low $232.25
Risk Considerations
Monitor position sizing based on current volatility levels
Consider stop-loss placement beyond recent price range
Diversification helps mitigate single-stock risk exposure

Growth of $10,000

Compare with Another Ticker

Monte Carlo Projection (10yr)

MS Insider Trading Analysis

Source: SEC Form 4
Bought
$5.6K
1 Transactions
Sold
$98.7M
25 Transactions
Insiders
23
Active Traders
$
Avg Transaction
$3.8M
Large trades
Date Insider Type Shares Value

Frequently Asked Questions

As of August 12, 2026, Morgan Stanley is trading at $215.07.
Insider activity shows a heavy insider selling with $1,360.4M in total sales versus $10.7M in total purchases, indicating significant selling pressure from insiders.
Morgan Stanley's reported revenue growth of 28% significantly outpaces the Financial Services sector average of 8.0%.
Morgan Stanley's technicals are mixed, with the stock trading above its 200-day and 20-day SMAs but below its 50-day SMA. The RSI is neutral at 45.61, and the MACD indicates a lack of strong momentum.
Morgan Stanley's P/E ratio of 17.36 is slightly above the sector average of 15.5, but its strong revenue growth provides some justification for this valuation.
Morgan Stanley offers a dividend yield of approximately 1.93%.
The outlook is neutral, with positive long-term technicals and strong revenue growth tempered by significant insider selling and a neutral RSI.